Demand Rising for 'Bootlegged' Weight-Loss Drug

(MedPage Today) -- Novo Nordisk's weight management drug semaglutide (Wegovy) has been in prolonged short supply due to "unprecedented demand," prompting increased--and questionable--interest in compounded formulations of the drug, physicians...